Literature DB >> 30387920

Timescales of developmental toxicity impacting on research and needs for intervention.

Philippe Grandjean1,2, Latifa Abdennebi-Najar3, Robert Barouki4, Carl F Cranor5, Ruth A Etzel6, David Gee7, Jerrold J Heindel8, Karin S Hougaard9, Patricia Hunt10, Tim S Nawrot11,12, Gail S Prins13, Beate Ritz14, Morando Soffritti15,16, Jordi Sunyer17, Pal Weihe18.   

Abstract

Much progress has happened in understanding developmental vulnerability to preventable environmental hazards. Along with the improved insight, the perspective has widened, and developmental toxicity now involves latent effects that can result in delayed adverse effects in adults or at old age and additional effects that can be transgenerationally transferred to future generations. Although epidemiology and toxicology to an increasing degree are exploring the adverse effects from developmental exposures in human beings, the improved documentation has resulted in little progress in protection, and few environmental chemicals are currently regulated to protect against developmental toxicity, whether it be neurotoxicity, endocrine disruption or other adverse outcome. The desire to obtain a high degree of certainty and verification of the evidence used for decision-making must be weighed against the costs and necessary duration of research, as well as the long-term costs to human health because of delayed protection of vulnerable early-life stages of human development and, possibly, future generations. Although two-generation toxicology tests may be useful for initial test purposes, other rapidly emerging tools need to be seriously considered from computational chemistry and metabolomics to CLARITY-BPA-type designs, big data and population record linkage approaches that will allow efficient generation of new insight; epigenetic mechanisms may necessitate a set of additional regulatory tests to reveal such effects. As reflected by the Prenatal Programming and Toxicity (PPTOX) VI conference, the current scientific understanding and the timescales involved require an intensified approach to protect against preventable adverse health effects that can harm the next generation and generations to come. While further research is needed, the main emphasis should be on research translation and timely public health intervention to avoid serious, irreversible and perhaps transgenerational harm.
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30387920      PMCID: PMC6497561          DOI: 10.1111/bcpt.13162

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  79 in total

1.  The removal of lead from gasoline: historical and personal reflections.

Authors:  H L Needleman
Journal:  Environ Res       Date:  2000-09       Impact factor: 6.498

2.  Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967.

Authors:  Gideon Koren; Yvette Navioz
Journal:  Ther Drug Monit       Date:  2003-04       Impact factor: 3.681

3.  Application of hair-mercury analysis to determine the impact of a seafood advisory.

Authors:  Pál Weihe; Philippe Grandjean; Poul J Jørgensen
Journal:  Environ Res       Date:  2005-02       Impact factor: 6.498

4.  Seven deadly sins of environmental epidemiology and the virtues of precaution.

Authors:  Philippe Grandjean
Journal:  Epidemiology       Date:  2008-01       Impact factor: 4.822

5.  The faroes statement: human health effects of developmental exposure to chemicals in our environment.

Authors:  Philippe Grandjean; David Bellinger; Ake Bergman; Sylvaine Cordier; George Davey-Smith; Brenda Eskenazi; David Gee; Kimberly Gray; Mark Hanson; Peter van den Hazel; Jerrold J Heindel; Birger Heinzow; Irva Hertz-Picciotto; Howard Hu; Terry T-K Huang; Tina Kold Jensen; Philip J Landrigan; I Caroline McMillen; Katsuyuki Murata; Beate Ritz; Greet Schoeters; Niels Erik Skakkebaek; Staffan Skerfving; Pal Weihe
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-02       Impact factor: 4.080

Review 6.  Developmental origins of health and disease: new insights.

Authors:  Mark A Hanson; Peter D Gluckman
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-02       Impact factor: 4.080

7.  Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.

Authors:  J Booij; P Bergmans; A Winogrodzka; J D Speelman; E C Wolters
Journal:  Synapse       Date:  2001-02       Impact factor: 2.562

Review 8.  Early life events and their consequences for later disease: a life history and evolutionary perspective.

Authors:  Peter D Gluckman; Mark A Hanson; Alan S Beedle
Journal:  Am J Hum Biol       Date:  2007 Jan-Feb       Impact factor: 1.937

9.  Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects.

Authors:  Ann P Streissguth; Fred L Bookstein; Helen M Barr; Paul D Sampson; Kieran O'Malley; Julia Kogan Young
Journal:  J Dev Behav Pediatr       Date:  2004-08       Impact factor: 2.225

10.  Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.

Authors:  Morando Soffritti; Fiorella Belpoggi; Eva Tibaldi; Davide Degli Esposti; Michelina Lauriola
Journal:  Environ Health Perspect       Date:  2007-09       Impact factor: 9.031

View more
  7 in total

1.  Development priority.

Authors:  Philippe Grandjean; Gail S Prins; Pal Weihe
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-06-28       Impact factor: 4.080

Review 2.  Down syndrome.

Authors:  Stylianos E Antonarakis; Brian G Skotko; Michael S Rafii; Andre Strydom; Sarah E Pape; Diana W Bianchi; Stephanie L Sherman; Roger H Reeves
Journal:  Nat Rev Dis Primers       Date:  2020-02-06       Impact factor: 52.329

3.  Exposure to Toenail Heavy Metals and Child Behavior Problems in Nine-Year-Old Children: A Cross-Sectional Study.

Authors:  Shamshad Karatela; Christin Coomarasamy; Janis Paterson; Neil I Ward
Journal:  Int J Environ Res Public Health       Date:  2020-06-09       Impact factor: 3.390

4.  Generation of a Triple-Transgenic Zebrafish Line for Assessment of Developmental Neurotoxicity during Neuronal Differentiation.

Authors:  Junko Koiwa; Takashi Shiromizu; Yuka Adachi; Makoto Ikejiri; Kaname Nakatani; Toshio Tanaka; Yuhei Nishimura
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-24

5.  Developmental exposure of California mice to endocrine disrupting chemicals and potential effects on the microbiome-gut-brain axis at adulthood.

Authors:  Sarabjit Kaur; Saurav J Sarma; Brittney L Marshall; Yang Liu; Jessica A Kinkade; Madison M Bellamy; Jiude Mao; William G Helferich; A Katrin Schenk; Nathan J Bivens; Zhentian Lei; Lloyd W Sumner; John A Bowden; Jeremy P Koelmel; Trupti Joshi; Cheryl S Rosenfeld
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

6.  Microplastics, environment and child health.

Authors:  Maria Elisabeth Street; Sergio Bernasconi
Journal:  Ital J Pediatr       Date:  2021-03-25       Impact factor: 2.638

Review 7.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.